Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -2543.74% is 273% below its 5-year average of -681.94%, near the high end of its 5-year range (-11575.86%–0.00%).
27.81% above its 12-month average of -3523.46%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -1884.77%.
NET PROFIT MARGIN
-2543.74%
NET PROFIT MARGIN AVG TTM
-3523.46%
NET PROFIT MARGIN AVG 3Y
-1169.90%
NET PROFIT MARGIN AVG 5Y
-681.94%
NET PROFIT MARGIN AVG 10Y
-4.81%
NET PROFIT MARGIN AVG 15Y
-0.83%
NET PROFIT MARGIN AVG 20Y
-2.57%
CURRENT VS TTM AVG
+27.81%
CURRENT VS 3Y AVG
-117.43%
CURRENT VS 5Y AVG
-273.01%
CURRENT VS 10Y AVG
-52831.76%
CURRENT VS 15Y AVG
-307707.35%
CURRENT VS 20Y AVG
-98951.33%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 517 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
CAMP4 Therapeutics Corporation
Market Cap
$251.01M
Net Profit Margin
-2543.74%
TTM Avg
-3523.46%
3Y Avg
-1169.90%
5Y Avg
-681.94%
Market Cap
$249.24M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$247.60M
Net Profit Margin
-155582.08%
TTM Avg
-91683.52%
3Y Avg
-62749.43%
5Y Avg
-41832.95%
Market Cap
$247.47M
Net Profit Margin
-183.90%
TTM Avg
-383.83%
3Y Avg
-191.92%
5Y Avg
-127.94%
Market Cap
$244.41M
Net Profit Margin
N/A
TTM Avg
-26.91%
3Y Avg
-35.21%
5Y Avg
-46.29%
Market Cap
$258.93M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$260.75M
Net Profit Margin
-10994.73%
TTM Avg
-520.92%
3Y Avg
-360.66%
5Y Avg
-288.77%
Market Cap
$241.18M
Net Profit Margin
-912.25%
TTM Avg
-448.06%
3Y Avg
-224.03%
5Y Avg
-224.03%
Market Cap
$240.55M
Net Profit Margin
-26.97%
TTM Avg
-50.02%
3Y Avg
-94.39%
5Y Avg
-87.59%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CAMP4 Therapeutics Corporation (CAMP) | $251.01M | -2543.74% | -3523.46% | -1169.90% | -681.94% |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $249.24M | 0.00% | 0.00% | 0.00% | 0.00% |
| InflaRx N.V. (IFRX)vs › | $247.60M | -155582.08% | -91683.52% | -62749.43% | -41832.95% |
| Invivyd, Inc. (IVVD)vs › | $247.47M | -183.90% | -383.83% | -191.92% | -127.94% |
| Lifecore Biomedical, Inc. (LFCR)vs › | $244.41M | N/A | -26.91% | -35.21% | -46.29% |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $258.93M | 0.00% | 0.00% | 0.00% | 0.00% |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $260.75M | -10994.73% | -520.92% | -360.66% | -288.77% |
| BioAge Labs Inc. (BIOA)vs › | $241.18M | -912.25% | -448.06% | -224.03% | -224.03% |
| Biodesix, Inc. (BDSX)vs › | $240.55M | -26.97% | -50.02% | -94.39% | -87.59% |
| Galectin Therapeutics Inc. (GALT)vs › | $240.38M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
-1488.3%
Net Profit Margin
-2543.7%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -1884.77% |
| 2026-03-31 | -1416.62% |
| 2025-12-31 | -11575.86% |
| 2025-09-30 | -1899.25% |
| 2025-06-30 | -840.81% |
| 2025-03-31 | -1449.07% |
| 2024-12-31 | -2036.66% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-08-31 | -3341.71% |
| 2023-05-31 | -5.69% |
| 2023-02-28 | -10.30% |
| 2022-11-30 | -6.00% |
| 2022-08-31 | -10.29% |
| 2022-05-31 | -18.81% |
| 2022-02-28 | -13.43% |
| 2021-11-30 | -16.63% |
| 2021-08-31 | -6.87% |
| 2021-05-31 | -2.44% |
| 2021-02-28 | -10.65% |
| 2020-11-30 | -26.91% |
| 2020-08-31 | -11.35% |
| 2020-05-31 | -17.98% |
| 2020-02-29 | -64.02% |
| 2019-11-30 | -7.68% |
| 2019-08-31 | -7.90% |
| 2019-05-31 | -9.76% |
| 2019-02-28 | 13.35% |
| 2018-11-30 | -0.59% |
| 2018-08-31 | -0.89% |
| 2018-05-31 | 8.97% |
| 2018-02-28 | -5.05% |
| 2017-11-30 | 12.60% |
| 2017-08-31 | 13.63% |
| 2017-05-31 | -3.01% |
| 2017-02-28 | -4.05% |
| 2016-11-30 | -1.83% |
| 2016-08-31 | 0.58% |
| 2016-05-31 | -2.92% |
| 2016-02-29 | 7.78% |
| 2015-11-30 | 5.19% |
| 2015-08-31 | 5.01% |
| 2015-05-31 | 6.20% |
| 2015-02-28 | 9.42% |
| 2014-11-30 | 6.36% |
| 2014-08-31 | 5.54% |
| 2014-05-31 | 4.57% |
| 2014-02-28 | 5.12% |
| 2013-11-30 | 6.62% |
| 2013-08-31 | 4.84% |
| 2013-05-31 | 3.14% |
| 2013-02-28 | 67.43% |
| 2012-11-30 | 9.37% |
| 2012-08-31 | 8.32% |
| 2012-05-31 | 9.53% |
| 2012-02-28 | 4.36% |
| 2011-11-26 | 5.19% |
| 2011-08-27 | 4.01% |
| 2011-05-28 | 1.50% |
| 2011-02-28 | 1.05% |
| 2010-11-27 | -0.61% |
| 2010-08-28 | -3.15% |
| 2010-05-29 | -9.40% |
| 2010-02-28 | -3.86% |
| 2009-11-28 | -4.30% |
| 2009-08-29 | -17.72% |
| 2009-05-30 | -17.20% |
| 2009-02-28 | -214.90% |
| 2008-11-29 | -7.11% |
| 2008-08-30 | -6.43% |
| 2008-05-31 | -1.78% |
| 2008-03-01 | -31.84% |
| 2007-12-01 | -183.81% |
| 2007-09-01 | -13.39% |
| 2007-06-02 | -23.95% |
| 2007-03-03 | 1.28% |
| 2006-11-30 | 1.47% |
| 2006-08-31 | 2.13% |
| 2006-05-31 | -73.52% |
| 2006-02-28 | 7.25% |
| 2005-11-30 | 8.44% |
| 2005-08-31 | 6.38% |
| 2005-05-31 | 4.16% |
| 2005-02-28 | 4.82% |
| 2004-11-30 | 3.13% |
| 2004-08-31 | 3.44% |
| 2004-05-31 | 2.91% |
| 2004-02-28 | 7.15% |
| 2003-11-30 | 7.80% |
| 2003-08-31 | 1.61% |
| 2003-05-31 | -5.94% |
| 2003-03-01 | 3.72% |
| 2002-11-30 | 3.78% |
| 2002-08-31 | 6.60% |
